[
  {
    "nct": "NCT07308860",
    "name": "FAME-3 Extended: longer survival follow-up",
    "source_url": "https://clinicaltrials.gov/study/NCT07308860",
    "retrieved_utc": "2026-11-11T08:59:47.219468+00:00",
    "status": "ACTIVE_NOT_RECRUITING",
    "registry_last_updated": "2025-12-30",
    "enrollment": 1500,
    "enrollment_type": "ACTUAL",
    "primary_completion": "2030-06-30",
    "primary_completion_type": "ESTIMATED",
    "design_summary": "Ten-year follow-up of the same 1,500 participants already randomized in FAME-3; the extension record is observational.",
    "endpoint_summary": "Overall survival at ten years.",
    "interpretation": "This is directly relevant to the mortality uncertainty in the main study, if stable-presentation results and follow-up completeness are reported. It adds follow-up time, not another independent randomized cohort. More follow-up does not guarantee adequate precision for a modest clinical margin."
  },
  {
    "nct": "NCT05831085",
    "name": "DEFINE-DM: contemporary PCI in diabetes",
    "source_url": "https://clinicaltrials.gov/study/NCT05831085",
    "retrieved_utc": "2026-11-11T08:59:47.068936+00:00",
    "status": "RECRUITING",
    "registry_last_updated": "2026-06-24",
    "enrollment": 1500,
    "enrollment_type": "ESTIMATED",
    "primary_completion": "2029-12-31",
    "primary_completion_type": "ESTIMATED",
    "design_summary": "Randomized imaging- and physiology-guided PCI versus standard CABG in people with type 2 diabetes and three-vessel disease; left-main disease is excluded.",
    "endpoint_summary": "Death, MI or stroke at two years.",
    "interpretation": "This tests a newer PCI strategy in an important high-risk group. It is not automatically stable-only: the listed exclusions rule out very recent STEMI but do not exclude every acute presentation. A composite noninferiority result, if reported, would not by itself establish mortality equivalence."
  },
  {
    "nct": "NCT05427370",
    "name": "STICH3C: ischemic ventricular dysfunction",
    "source_url": "https://clinicaltrials.gov/study/NCT05427370",
    "retrieved_utc": "2026-11-11T08:59:47.064222+00:00",
    "status": "RECRUITING",
    "registry_last_updated": "2026-10-19",
    "enrollment": 754,
    "enrollment_type": "ESTIMATED",
    "primary_completion": "2029-04",
    "primary_completion_type": "ESTIMATED",
    "design_summary": "Randomized PCI versus CABG in patients with ejection fraction at most 40% and multivessel or left-main disease, suitable for both procedures.",
    "endpoint_summary": "Time to death, stroke, spontaneous MI, urgent repeat revascularization or heart-failure readmission, with median follow-up planned at five years.",
    "interpretation": "This addresses ventricular dysfunction rather than the general stable, non-left-main population. Its eligibility and endpoint need to be retained when interpreting eventual results; it cannot simply be pooled with a lower-risk stable subgroup."
  },
  {
    "nct": "NCT07269366",
    "name": "STICH 3.0-NL: related ventricular-dysfunction work",
    "source_url": "https://clinicaltrials.gov/study/NCT07269366",
    "retrieved_utc": "2026-11-11T08:59:47.052844+00:00",
    "status": "RECRUITING",
    "registry_last_updated": "2026-05-12",
    "enrollment": 358,
    "enrollment_type": "ESTIMATED",
    "primary_completion": "2034-05",
    "primary_completion_type": "ESTIMATED",
    "design_summary": "Randomized CABG versus PCI with ejection fraction at most 40%; multivessel disease may include left-main disease. The summary states participation in the international STICH 3.0 collaboration.",
    "endpoint_summary": "A hierarchical comparison of death, major cardiovascular events and heart-failure admissions at four years.",
    "interpretation": "A hierarchical win-based endpoint is a different estimand from a first-event composite or mortality hazard ratio. Distinct registry records need not represent independent programmes or cohorts; do not sum planned enrollment without resolving collaboration and overlap."
  },
  {
    "nct": "NCT06566183",
    "name": "ISCHEMIA-LVD: includes a medical-therapy arm",
    "source_url": "https://clinicaltrials.gov/study/NCT06566183",
    "retrieved_utc": "2026-11-11T08:59:47.058715+00:00",
    "status": "SUSPENDED",
    "registry_last_updated": "2026-06-05",
    "enrollment": 1200,
    "enrollment_type": "ESTIMATED",
    "primary_completion": "2030-12",
    "primary_completion_type": "ESTIMATED",
    "design_summary": "A three-arm randomized registration for guideline-directed medical therapy, CABG and PCI in multivessel disease with ejection fraction at most 40%.",
    "endpoint_summary": "Listed primary measures include cognition, heart-failure health status, and a death/MI/stroke/heart-failure-admission composite at twelve months.",
    "interpretation": "The registry says suspended and temporarily paused. A proposed three-way comparison is not available evidence that one strategy is better, nor a guarantee that the study will start or finish."
  },
  {
    "nct": "NCT01311323",
    "name": "MILESTONE",
    "source_url": "https://clinicaltrials.gov/study/NCT01311323",
    "retrieved_utc": "2026-11-11T08:59:47.230863+00:00",
    "status": "RECRUITING",
    "registry_last_updated": "2026-07-08",
    "enrollment": 1000,
    "enrollment_type": "ESTIMATED",
    "primary_completion": "2028-12",
    "primary_completion_type": "ESTIMATED",
    "design_summary": "Randomized PCI versus CABG for acute non-ST-elevation coronary syndromes.",
    "endpoint_summary": "One-year endpoints differ; see source registration.",
    "interpretation": "Explicitly excludes stable presentation; adjacent evidence, not a stable-only comparison."
  },
  {
    "nct": "NCT06279663",
    "name": "NSTE-ACSMT",
    "source_url": "https://clinicaltrials.gov/study/NCT06279663",
    "retrieved_utc": "2026-11-11T08:59:47.218114+00:00",
    "status": "RECRUITING",
    "registry_last_updated": "2024-03-13",
    "enrollment": 460,
    "enrollment_type": "ESTIMATED",
    "primary_completion": "2028-12-31",
    "primary_completion_type": "ESTIMATED",
    "design_summary": "Randomized PCI versus CABG for acute non-ST-elevation coronary syndromes.",
    "endpoint_summary": "One-year endpoints differ; see source registration.",
    "interpretation": "Explicitly excludes stable presentation; adjacent evidence, not a stable-only comparison."
  }
]
